RFA-HG-12-016 "Clinically relevant genetic variants resource: a unified approach for identifying genetic variants for clinical use (U01)."
The PharmGKB team is excited to see this RFA because clinical genomics has great potential to impact medicine. PharmGKB catalogs genetic variation of relevance to drug response (pharmacogenomics) and moves research data to guidelines for clinical action. We do not intend to apply for this RFA and we look forward to working with the grantee(s) under this program, who we presume will primarily focus on clinically actionable variants relevant to disease risk.
